XML 30 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating activities      
Net income (loss) $ 48 $ (311) $ 200
Depreciation 393 365 365
Amortization 23 23 24
Amortization of deferred financing charges 5 5 6
Redemption premium on debt     21
Write-off of deferred financing costs 1   8
Earnings of affiliates, net of dividends received 11 23 (10)
Stock compensation expense 26 19 17
Deferred income taxes (104) 153 (1)
Pension expense, net 3 (1) (1)
Gain on sale leaseback (66)
Impairment of goodwill   191  
Change in working capital 70 199 (455)
Change in other noncurrent assets and liabilities 11 9 (3)
Other, net (11) (26) 53
Net cash provided by operating activities 476 649 158 Close
Investing activities      
Purchases of property, plant and equipment (501) (440) (369)
Proceeds from sale of property, plant and equipment 2 3 85
Acquisition of businesses, net of cash acquired   (1) (18)
Investments in affiliates     (23)
Purchases of marketable securities   (15) (32)
Proceeds from sales of marketable securities     30
Proceeds from maturities of marketable securities   30 35
Proceeds from sale of equity affiliate     29
Proceeds from sale of subsidiaries, net of cash disposed     (4)
Other, net (16) 5  
Net cash used in investing activities (528) (426) (293) Close
Financing activities      
Net change in short-term debt (30) 33 (3)
Proceeds from long-term debt 458 2 1,157
Repayment of long-term debt (209) (24) (1,156)
Redemption premium on debt     (21)
Deferred financing payments (9)   (18)
Dividends paid to common stockholders (58) (58) (58)
Repurchases of common stock   (25) (23)
Distributions to noncontrolling interests (10) (9) (15)
Contributions from redeemable noncontrolling interests 22 51 14
Deconsolidation of non-wholly owned subsidiary     (6)
Payments to acquire noncontrolling interests   (4)  
Other, net (4) (8) 2
Net cash provided by (used in) financing activities 160 (42) (127) Close
Net increase (decrease) in cash, cash equivalents and restricted cash 108 181 (262) Close
Cash, cash equivalents and restricted cash - beginning of period 442 287 567
Effect of exchange rate changes on cash balances 13 (26) (18)
Cash, cash equivalents and restricted cash - end of period 563 442 287
Not Designated as Hedging Instrument [Member]      
Investing activities      
Settlement of derivatives $ (13) $ (8) (4)
Currency Swap [Member]      
Investing activities      
Settlement of derivatives     $ (22)